Industry News

Theravance Biopharma, Inc. announced today that stock options to purchase an aggregate of 24,800 of the Company's ordinary shares were granted to seven new non-executive officer employees on July 1, 2016. The options were granted in accordance with NASDAQ Listing Rule 5635 (c) under the Theravance Biopharma, Inc. 2014 New Employee Equity Incentive Plan, which the Board of Directors of Theravance Biopharma adopted in October 2014 to facilitate the..."/>
Theravance Biopharma Announces New Employment Inducement Awards
AMSURG Corp., today announced the acquisition of Resolute Anesthesia and Pain Solutions and South Lake Anesthesia Services, P.A., further expanding its anesthesiology services business in Florida, New Jersey and Missouri and establishing its initial presence in Illinois. Resolute Anesthesia and Pain Solutions, headquartered in Boca Raton, Florida, is one of the largest ambulatory-based anesthesiology..."/>
AMSURG’s Physician Services Division – Sheridan – Acquires Resolute Anesthesia and Pain Solutions and South Lake Anesthesia Services
TeamHealth Holdings, Inc., a leading physician services organization, announced the acquisition of the operations of Lake County Anesthesia Associates based in central Florida. Lake County Anesthesia Associates currently provides anesthesia services for Leesburg Regional Medical Center in Leesburg, Florida, and The Villages ® Regional Hospital in The Villages, Florida, both of which are part of Central Florida Health."/>
TeamHealth to Provide Integrated Services for Central Florida Health, Acquires Operations of Lake County Anesthesia Associates
Allscripts Healthcare Solutions, Inc. will report its financial results for the three months ended June 30, 2016, after the close of regular stock market hours on Thursday, August 4, 2016. Allscripts management plans to host a conference call and webcast to discuss the company's earnings and other information at 4:30 p.m. Eastern Time that same day.. More Details on the Second Quarter 2016 Financial Results Call."/>
Allscripts to release second quarter 2016 financial results August 4
Akebia Therapeutics, Inc., a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor, today announced that John P. Butler, President and Chief Executive Officer, will present at the 2 nd Annual Cantor Fitzgerald Healthcare Conference on Tuesday, July 12, 2016 at 4:00 p.m. Eastern Time. The conference is being held at Le Parker Meridien in New York City."/>
Akebia to Present at the Cantor Fitzgerald Annual Healthcare Conference
AmerisourceBergen Corporation today announced that it plans to release its results for the Third Quarter Fiscal 2016 on Tuesday, August 2, 2016 prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 11:00 a.m. Eastern Time on August 2, 2016.. Participating in the conference call will be:."/>
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2016 Earnings Release
Cytokinetics, Inc. announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at Cantor Fitzgerald’ s 2 nd Annual Healthcare Conference on Tuesday, July 12, 2016 at 1:00 PM ET at Le Parker Meridien in New York, NY.. Interested parties may access the live webcast of this presentation by visiting the Investors& Media section of the Cytokinetics website at www.cytokinetics.com."/>
Cytokinetics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
M and A Navigator: Deal pipeline –5 July
Teva Pharmaceutical Industries Ltd.' s acquisition of Allergan's generic division are affecting the uncertainty concerning the Teva share. The deal, which Teva predicted would be completed in June, has not been completed yet; Teva is still waiting for final approval from the Federal Trade Commission, which is responsible for antitrust matters. The Credit Suisse investment bank believes that the deal will be completed soon, and that the key..."/>
Indian co might buy Teva product lines for $1.5b - report [Globes, Tel Aviv, Israel]
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, today announced the closing of its previously announced public offering of 2,378,823 Class A units, with each Class A unit consisting of one American Depositary Share, traded on the NASDAQ under the symbol "KTOV", and a warrant to purchase one ADS, traded on the NASDAQ under the symbol "KTOVW", as well as 1,150,589 Class B units, with each..."/>
Kitov Pharmaceuticals Announces Closing of a $12 Million Follow-On Public Offering in the U.S.A.
HealthSouth Corp. are partnering to build a $12.2 million, 35- bed rehabilitation hospital on the third floor of BJC's Barnes-Jewish St. Louis-based BJC said Tuesday it filed a certificate of need with the State of Missouri for the hospital slated to open in summer 2017 after a nine-month construction process. The 39,000- square-foot hospital, which will add 86 jobs in its first year, will serve as a satellite location of existing inpatient..."/>
BRIEF: BJC, HealthSouth to build $12.2 million rehab hospital in St. Peters [St. Louis Post-Dispatch]
Biotech networking event Saturday in Sunrise [Sun Sentinel]
NuVasive Inc., a leading medical device company, announced today it successfully completed the acquisition of Biotronic NeuroNetwork. The boards of directors of both companies approved a definitive agreement, under which San Diego-based NuVasive will acquire Biotronic for $98 million cash. "We are very excited to announce the completion of the Biotronic acquisition, as it advances NuVasive's strategy to transform how spine procedures are approached, measured and..."/>
Medical device company completes acquisition of Biotronic [Dayton Daily News, Ohio]
Unilife Corporation. Investors who purchased or otherwise acquired shares between February 3, 2014 and May 23, 2016 inclusive, are encouraged to contact the Firm prior to the July 25, 2016 lead plaintiff motion deadline.. If you purchased shares of Unilife during the Class Period, please contact Joon M. Khang, Esquire, of Khang& Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by..."/>
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Unilife Corporation and Reminds Investors With Losses to Contact the Firm
XOMA Corporation, a leader in the discovery and development of therapeutic antibodies, announced today that Dr. Paul Rubin, the Company’ s Senior Vice President, Research and Development& Chief Medical Officer, is scheduled to present at the Cantor Fitzgerald Healthcare Conference on Tuesday, July 12, 2016, at 9:30 a.m. ET.. A live audio webcast of the presentation can be accessed in the Investors and Media section of XOMA's website at..."/>
XOMA to Present at the Cantor Fitzgerald Healthcare Conference
Lipocine Inc. concerning possible violations of federal securities laws between June 30, 2015 and June 28, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 30, 2016 lead plaintiff motion deadline.. To participate in this class action lawsuit, click here to participate."/>
IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm
Inovalon, Inc. concerning possible violations of federal securities laws in connection with Inovalon’ s initial public offering. Investors who purchased or otherwise acquired shares on or about the February 12, 2015 IPO are encouraged to contact the firm in advance of the August 23, 2016 lead plaintiff motion deadline. If you are a shareholder who purchased or otherwise acquired shares..."/>
SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Inovalon Holdings, Inc. And Encourages Investors With Losses To Contact the Firm
Ampio Pharmaceuticals, Inc. hosting a conference call today Tuesday, July 5th at 4:30pm ET. Participants are invited to dial in using the instructions as follows:. Investor call information: U.S./ Canada toll-free number: 866-675-4790 International toll number: 913-312-0685 Participant Passcode: 4091988."/>
Ampio Hosting Conference Call Today, July 5, 4:30pm ET
Cambrex Corporation is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the Cantor Fitzgerald 2 nd Annual Healthcare Conference on July 12, 2016 at 4:00 p.m. EDT in New York City.. The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under“ Webcasts& Presentations,” and a replay will be available for 90 days after the live..."/>
Cambrex to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
Select Medical Holdings Corporation, will release the financial results for its second quarter ended June 30, 2016 on Thursday, August 4, 2016 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 5, 2016, at 9:00am ET. The domestic dial in number for the call is 1-877-430-7741. The international dial in number is 1-615-247-0054. The..."/>
Select Medical Holdings Corporation to Announce Second Quarter 2016 Results on Thursday, August 4
BioTime, Inc., a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine, today announced that the underwriters of BioTime, Inc.’ s previously announced public offering that initially closed on June 21, 2016, have purchased an additional 1,098,326 shares of BioTime, Inc.’ s common stock at a price of $2.39 per share, before deducting the underwriting discount, in connection with..."/>
BioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials602 Articles
Consumer Discretionary542 Articles
Information Technology528 Articles
Industrials410 Articles
Health Care354 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.